We believe that almost every disease has an immune component.

Thus, we are unlocking new ways, in silico, in vitro, and in vivo, to study immune cells that will shed light on mechanisms of diseases such as cancer, autoimmune and infectious diseases. This will allow us to develop new therapeutics that help us fight against these diseases.

ML has revolutionized genomic and clinical research. Deep learning is increasingly being applied to answer big, previously unattainable research questions in genomics.

The scale, heterogeneity, and high dimensionality of the data generated from single-cell sequencing, combined with the inherent immense complexity of the immune system, presents a uniquely relevant space for ML applications to develop novel and important insights.

Our team is embracing the opportunity and leveraging ML for various challenges ranging from identifying subtle changes in cell types and states to finding predictive biomarkers of response or resistance to specific therapeutic regimens.

We are focused on developing state-of-the-art computational methods to leverage single-cell data’s potential fully.

Our computational methods, combined with our extensive in-house single-cell dataset, provide us with a high-resolution understanding of the immune response even in rare cell types, which we apply to developing new drugs and improving current therapeutics across multiple diseases.

With the constant advances in single-cell technologies, many more challenges await!

In software, our job is to enable Immunai’s scientists to ask questions on novel datasets at an unprecedented scale.

We are constantly innovating on the world’s largest single-cell sequencing data platform. We process and organize hundreds of terabytes of single-cell sequencing data- a scale that is an industry first. Our pipeline, a collaboration between software engineers, computational biologists, and immunologists, extracts insights from high-dimensional datasets with autonomy, reproducibility, and flexibility. The result is tools that remove the burden of technical problems such as data scale and provenance and empower our science.

We apply state-of-the-art multimodal single-cell approaches and continue to develop new assays that allow us to extract even more data and deeper layers of molecular insights from every cell.

We also leverage the power of single cell data in combination with functional genomic technologies to inform new therapeutic discoveries and advance next-generation therapies. All this helps us increase our understanding of the immune system.

We are building a team of scientists to translate the insights that we obtain for our data platform into drug discovery efforts.

The people in the therapeutics discovery team develop in vitro and in vivo data packages that support moving our drug candidates into clinical trials in cancer and inflammatory diseases.

Product management sits at the intersection of our business and research and development organizations and obsesses over profoundly understanding the challenges and opportunities facing our customers and the broader market where we operate.

Working cross-functionally, product managers aim to define a strong thesis of the ‘why’ and ‘so what’ of what we build to develop a compelling vision, strategy, and roadmap for the product offerings that will allow us to deliver value to our customers and our business. Product managers also partner closely with various development orgs to build and ship compelling products and iterate on them until they achieve their intended goal.

We oversee the execution of Immunai’s business strategy, encompassing five key divisions – Business Development; Corporate Development; Marketing; Alliance Management, and Intellectual Property (IP) Strategy.

We represent Immunai externally, including partnership interactions, M&A, brand strategy, and asset management to execute on our long-term vision and drive sustainable growth.

Operations at Immunai support five global sites to achieve operating targets, improve efficiencies, and enable the company to scale the business as we implement our strategic vision.

The team is accountable for Project Management across the company, as well as Logistics, Procurement, Vendor Management, Process Improvement, Facilities, IT Support, Travel, and the Biorepository. Our team works diligently to provide our scientific teams with the infrastructure they need to realize their vision. The group is composed of exceptional individuals with scientific, strategic and operational capabilities.